The interstitial cells of Cajal of the equine gastrointestinal tract: What we know so far

被引:6
|
作者
Fintl, C. [1 ]
Hudson, N. P. H. [2 ]
机构
[1] Norwegian Sch Vet Sci, Dept Compan Anim Clin Sci, N-0033 Oslo, Norway
[2] Univ Edinburgh, Royal Dick Sch Vet Studies, Easter Bush Vet Ctr, Roslin EH25 9RG, Midlothian, Scotland
关键词
ELECTRICAL SLOW WAVES; DEEP MUSCULAR PLEXUS; KIT-POSITIVE CELLS; C-KIT; SMOOTH-MUSCLE; STROMAL TUMORS; DELAYED MATURATION; IONIC CONDUCTANCES; CIRCULAR MUSCLE; CARBON-MONOXIDE;
D O I
10.1111/j.2042-3306.2010.00073.x
中图分类号
S85 [动物医学(兽医学)];
学科分类号
0906 ;
摘要
P>Gastrointestinal motility disorders are a serious problem in both veterinary and human medicine and may represent a dysfunction of the neural, muscular or pacemaker components (interstitial cells of Cajal) of bowel control. The interstitial cells of Cajal are considered to be the pacemakers and mediators of certain forms of neurotransmission in the gastrointestinal tract. These cells have been implicated, either primarily or secondarily, in the pathogenesis of gastrointestinal disease processes in which there is a prominent element of disturbance to intestinal motility. In the horse, their involvement has been implicated in large intestinal obstructive colic and grass sickness (equine dysautonomia). This review highlights the properties of the interstitial cells of Cajal and the role these cells play in orchestrating gastrointestinal motility patterns. In addition, it examines their role in intestinal motility disorders and summarises our current understanding of their importance in the equine gastrointestinal tract.
引用
收藏
页码:372 / 377
页数:6
相关论文
共 50 条
  • [41] Scalp Seborrheic Dermatitis: What We Know So Far
    Leroy, Anne Kelly
    de Almeida, Rita Fernanda Cortez
    Obadia, Daniel Lago
    Frattini, Sidney
    Melo, Daniel Fernandes
    SKIN APPENDAGE DISORDERS, 2023, 9 (03) : 160 - 164
  • [42] Neuroproteomics in Epilepsy: What Do We Know so Far?
    do Canto, Amanda M.
    Donatti, Amanda
    Geraldis, Jaqueline C.
    Godoi, Alexandre B.
    da Rosa, Douglas C.
    Lopes-Cendes, Iscia
    FRONTIERS IN MOLECULAR NEUROSCIENCE, 2021, 13
  • [43] TAVI in nonagenarians, what do we know so far?
    Diez-Villanueva, Pablo
    Rivero, Fernando
    REC-INTERVENTIONAL CARDIOLOGY, 2021, 3 (04): : 245 - 246
  • [44] Strongly Quasiconvex Functions: What We Know (So Far)
    Sorin-Mihai Grad
    Felipe Lara
    Raúl T. Marcavillaca
    Journal of Optimization Theory and Applications, 2025, 205 (2)
  • [45] China coronavirus: what do we know so far?
    Mahase, Elisabeth
    BMJ-BRITISH MEDICAL JOURNAL, 2020, 368 : m308
  • [46] Refractory hypertension: what do we know so far?
    Muxfeldt, Elizabeth Silaid
    Chedier, Bernardo
    JOURNAL OF HUMAN HYPERTENSION, 2021, 35 (03) : 181 - 183
  • [47] Diet in the Treatment of Epilepsy: What We Know So Far
    Verrotti, Alberto
    Iapadre, Giulia
    Di Francesco, Ludovica
    Zagaroli, Luca
    Farello, Giovanni
    NUTRIENTS, 2020, 12 (09) : 1 - 19
  • [48] Trends in HeartMate 3: What we know so far
    Lanfear, Allison T.
    Hamandi, Mohanad
    Fan, Joy
    DiMaio, J. Michael
    George, Timothy J.
    JOURNAL OF CARDIAC SURGERY, 2020, 35 (01) : 180 - 187
  • [49] Visual snow syndrome: what we know so far
    Puledda, Francesca
    Schankin, Christoph
    Digre, Kathleen
    Goadsby, Peter J.
    CURRENT OPINION IN NEUROLOGY, 2018, 31 (01) : 52 - 58
  • [50] Mitochondrial cytopathy in adults: What we know so far
    Cohen, BH
    Gold, DR
    CLEVELAND CLINIC JOURNAL OF MEDICINE, 2001, 68 (07) : 625 - +